Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Alexion Pharmaceuticals, Inc.
Study ID
NCT04202341
Status
Recruiting
Apply to this trial

Conditions

  • Generalized Myasthenia Gravis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Long-term, multicenter, multinational, observational, registry of patients with gMG that is designed to collect data on clinical outcomes and safety in patients prescribed Alexion C5 inhibitor therapies (C5IT) such as eculizumab (Soliris®) and ravulizumab (Ultomiris®).

Key Dates

Start date
Dec 2, 2019
Status verified
Feb 2026
Primary completion
Oct 1, 2029
Completion
Oct 1, 2029

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

Change in Myasthenia Gravis Activities of Daily Living (MG-ADL) Score [ Time Frame: Approximately 5 years from enrollment ]

Central Contacts

Locations (32)

FacilityCityStateZIPSite coordinators
Clinical Trial SiteBirminghamAlabama35294-
Clinical Trial SiteScottsdaleArizona85251-
Clinical Trial SiteFresnoCalifornia93710-
Clinical Trial SiteOrangeCalifornia92868-
Clinical Trial SiteRancho MirageCalifornia92270-
Clinical Trial SiteSylmarCalifornia91342-
Clinical Trial SiteColorado SpringsColorado80907-
Clinical Trial SiteFort CollinsColorado80528-
Clinical Trial SiteNew HavenConnecticut06520-
Clinical Trial SiteWashington D.C.District of Columbia10010-
Clinical Trial SiteClearwaterFlorida33761-
Clincal Trial SiteGainesvilleFlorida32608-
Clinical Trial SiteJacksonvilleFlorida32209-
Clinical Trial SiteTampaFlorida33612-
Clinical Trial SiteAugustaGeorgia30912-
Clinical Trial SiteIowa CityIowa52242-
Clinical Trial SiteLexingtonKentucky40503-
Clinical Trial SiteBostonMassachusetts02215-
Clinical Trial SiteLansingMichigan48824-
Clinical Trial SiteColumbiaMissouri65212-
Clinical Trial SiteNew Hyde ParkNew York11042-
Clinical Trial SiteChapel HillNorth Carolina27599-
Clinical Trial SiteCharlotteNorth Carolina28207-
Clinical Trial SiteDurhamNorth Carolina27705-
Clinical Trial SiteDaytonOhio45459-
Clinical Trial SitePhiladelphiaPennsylvania19104-
Clinical Trial SiteChattanoogaTennessee37403-
Clinical Trial SiteKnoxvilleTennessee37920-
Clinical Trial SiteDallasTexas75206-
Clinical Trial SiteHoustonTexas77030-
Clinical Trial SiteBurlingtonVermont05401-
Clinical Trial SiteMilwaukeeWisconsin53215-

Find similar trials in Birmingham, AL

By research site
Clinical Trial Site· Birmingham, ALClinical Trial Site· Scottsdale, AZClinical Trial Site· Fresno, CAClinical Trial Site· Orange, CAClinical Trial Site· Rancho Mirage, CAClinical Trial Site· Sylmar, CA

Related Studies